New answer by Medical Oncologist at H Lee Moffitt Cancer Center, University of South Florida (July 30, 2023)
Doing a 5FU/capecitabine rechallenge after vasospasm can be risky and fatalities have been reported. Capecitabine and infusion 5FU are riskier than bolus 5FU due to prolonged ...